Table II.
Recommended COVID-19 Nucleic Acid Detection Techniques
| Organization conducted the study | Test principle | Sensitivity of test | Manufacturer/commercially available devices | Reference |
|---|---|---|---|---|
| Huazhong University of Science and Technology, Wuhan, China |
Chest CT RT-PCR |
Chest CT 97% RT-PCR 59% |
- | (11) |
| Fred Hutchinson Cancer Research Center, WA, USA | Real-time RT-PCR | 84.6% |
Xpert® Xpress by Cepheid Roche Molecular System |
(12) |
| University of California, San Francisco, USA | CRISPR | Not reported |
Cepheid Sherlock Biosciences Mammoth Biosciences |
(13) |
| Wuhan Institute of Virology, China | Isothermal nucleic acid amplification technology | 95% | Abbott® ID Now | (7,14,15) |
CT- Computed Tomography; RT-PCR- Reverse Transcriptase- Polymerase chain reaction; CRISPR- Clustered Regularly Interspaced Short Palindromic Release